|
|
|
|
| LEADER |
01839nam a2200277 u 4500 |
| 001 |
EB002000541 |
| 003 |
EBX01000000000000001163442 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
210907 r ||| eng |
| 100 |
1 |
|
|a Staples, Heidi
|
| 245 |
0 |
0 |
|a Cannabinoids for behavioural symptoms in adults with dementia
|h Elektronische Ressource
|b a review of clinical effectiveness and guidelines
|c Heidi Staples, Lorna Adcock
|
| 260 |
|
|
|a Ottawa (ON)
|b CADTH
|c 2017, January 5, 2017
|
| 300 |
|
|
|a 1 PDF file (23 pages)
|b illustration
|
| 653 |
|
|
|a Behavioral Symptoms / drug therapy
|
| 653 |
|
|
|a Dementia / drug therapy
|
| 653 |
|
|
|a Cannabinoids / therapeutic use
|
| 653 |
|
|
|a Treatment Outcome
|
| 700 |
1 |
|
|a Adcock, Lorna
|e [author]
|
| 710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a CADTH rapid response report: summary with critical appraisal
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK526373
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a Antipsychotics have historically been used off-label for treating dementia-related behavioural symptoms in adults residing in long-term care, but the modest benefit of treatment was found to be outweighed by the harms - including an increased risk of death - for most people. Thus, the use of antipsychotics has generally been reserved for shortterm treatment of the most severe cases of aggression. Identifying safer, more effective alternatives to antipsychotics is a priority. One such potential alternative under investigation is the use of cannabinoids. The objective of this report was to review the evidence base for the use of cannabinoids in the treatment of behavioural symptoms in adults with dementia
|